WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004093914) FORMULATIONS FOR TREATMENT OF PULMONARY DISORDERS COMPRISING A BRONCHODILATOR, A VASOCONSTRICTOR AND A CORTICOSTEROID
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/093914    International Application No.:    PCT/US2004/008329
Publication Date: 04.11.2004 International Filing Date: 17.03.2004
IPC:
A61K 31/137 (2006.01), A61K 45/06 (2006.01)
Applicants: TEDOR PHARMA, INC. [US/US]; 400 Highland Corporate Drive, Cumberland, RI 02864 (US) (For All Designated States Except US).
KAPLAN, Leonard, W. [US/US]; (US) (For US Only)
Inventors: KAPLAN, Leonard, W.; (US)
Agent: EBERLE, Shelley, P.; Reed Intellectual Property Law Group, 1400 Page Mill Road, Palo Alto, CA 94304-1124 (US)
Priority Data:
10/402,771 28.03.2003 US
Title (EN) FORMULATIONS FOR TREATMENT OF PULMONARY DISORDERS COMPRISING A BRONCHODILATOR, A VASOCONSTRICTOR AND A CORTICOSTEROID
(FR) FORMULATIONS DESTINEES AU TRAITEMENT DE TROUBLES PULMONAIRES, REUNISSANT UN BRONCHODILATATEUR, UN VASOCONSTRICTEUR ET UN CORTICOSTEROIDE
Abstract: front page image
(EN)Pharmaceutical formulations useful for the treatment of pulmonary disorders are described. These compositions are formulated for pulmonary administration and contain a bronchodilator, a vasoconstrictor, a corticosteroid, and an optional pharmaceutically acceptable carrier. Drug delivery devices and dosage forms for housing and/or dispensing the formulations are also described.
(FR)La présente invention concerne des formulations pharmaceutiques convenant au traitement de troubles pulmonaires. Formulées pour une administration pulmonaire, ces compositions réunissent un bronchodilatateur, un vasoconstricteur, un corticostéroïde, et éventuellement un vecteur pharmaceutiquement admis. L'invention concerne également des dispositifs d'administration et des formes posologiques pour le conditionnement et/ou l'administration de ces formulations.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)